U.S. Markets closed

ALPS Medical Breakthroughs ETF (SBIO)

NYSEArca - NYSEArca Delayed Price. Currency in USD
Add to watchlist
41.83+0.70 (+1.70%)
At close: 4:00PM EDT
Full screen
Trade prices are not sourced from all markets
Previous Close41.13
Open41.42
Bid38.00 x 1100
Ask42.25 x 900
Day's Range41.09 - 41.83
52 Week Range25.10 - 45.02
Volume17,699
Avg. Volume22,573
Net Assets190.27M
NAV41.15
PE Ratio (TTM)N/A
Yield0.04%
YTD Daily Total Return-2.48%
Beta (5Y Monthly)1.40
Expense Ratio (net)0.50%
Inception Date2014-12-30
  • ETF Database

    A Targeted ETF to Track Medical Breakthroughs

    An exchange traded fund that focuses on medical breakthroughs helps investors gain exposure to some of the cutting edge innovations in the healthcare industry.

  • ETF Trends

    Smaller Companies, Big Returns For This Biotech ETF

    The ALPS Medical Breakthroughs ETF (SBIO) was a star performer among healthcare ETFs last year and with small- and mid-cap members of that sector looking poised to renew bullish trends this year, SBIO could again deliver for investors. SBIO focuses on small- and mid-cap companies that have one or more drugs in either Phase II or Phase III trials. The component holdings have one or more drugs in either Phase II or Phase III U.S. Food and Drug Administration clinical trials.

  • 4 Sector ETFs That Beat the Market in Q4
    Zacks

    4 Sector ETFs That Beat the Market in Q4

    While Wall Street is surging this quarter, these sector ETFs offered even better performances to beat the market.